On 16 August 2019, by electronic vote, the Global Fund Board approved funding for three country grants worth $32.7 million (Colombia HIV, Honduras TB/HIV and Kazakhstan TB). Domestic commitments for the programs included in the approved country grants amounted to $1.17 billion. Initiatives valued at $2.4 million were added to the Unfunded Quality Demand (UQD) Register. (See Table 1.)
You are here
Global Fund’s new HIV and TB multicountry grants in Eastern Europe and Central Asia begin implementation
The Global Fund Board has recently approved several multicountry grants, whose aim is to address priorities “deemed critical to fulfil the aims of the Global Fund 2017-2022 strategy,” and to address needs that are not being fulfilled by national (single country) allocations.
A comparative study of opioid substitution therapy protocols will contribute to the sustainability of harm reduction in the Eastern Europe and Central Asia region
The new methodology for the funding allocations and consequent gradual decrease of GF financing for the Eastern Europe and Central Asia (EECA) countries puts at special risk the operations of harm reduction services, which were, traditionally, largely supported by the GF.
Расследование ОГИ раскрывает доказательства сговора, мошенничества и коррупции при деятельности, связанной с закупками в Казахстане
Расследование, проведенное Управлением Генерального Инспектора (ОГИ) в сфере закупкок для нужд грантов по ВИЧ и ТБ в Казахстане, выявило доказательства систематического сговора, мошенничества и коррупции со стороны местных поставщиков и других заинтересованных сторон, компромитирующие 76 контрактов на общую сумму 16,5 млн долларов. Обособленно, схожие проблемы в меньшем масштабе были раскрыты в Йемене.
OIG investigation uncovers evidence of collusion, fraud and corruption in procurement activities in Kazakhstan
An investigation by the Office of the Inspector General (OIG) into procurement in HIV and TB grants to Kazakhstan found evidence of systematic collusion, fraud and corruption by local vendors and other parties that compromised 76 contracts worth $16.5 million. Separately, similar problems on a smaller scale were uncovered in Yemen.
An investigation by the Office of the Inspector General (OIG) into three HIV grants in Kazakhstan administered by the principal recipient, the Republican Center for Prophylactics and Control of AIDS (RCAIDS), has found evidence of attempted misappropriation, misuse of grant funds, misrepresentation and anti-competitive and collusive practices.
Kazakhstan is one of the six early applicant countries in the transition phase of the new funding model (see GFO article). It will be submitting a concept note for its TB programmes.